1.5 Harmonic Imaging Sonography with microbubble contrast agent improves characterization of hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 11, Issue 36, 2005, Pages 5607-5613

  Yamamoto, Kouji ^a   Shiraki, Katsuya ^a   Nakanishi, Shigeo ^a   Fuke, Hiroyuki ^a   Nakano, Takeshi ^a   Hashimoto, Akira ^b   Shimizu, Atsuya ^b   Hamataki, Toshinobu ^c  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAISEIKAI MATSUSAKA GENERAL HOSPITAL   (Japan)

^c TOSHIBA MEDICAL SYSTEMS CORPORATION   (Japan)

Author keywords

1.5 Harmonic Imaging Sonography; Hepatocellular carcinoma; Microbubble

Indexed keywords

SHU 508;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIGITAL SUBTRACTION ANGIOGRAPHY; FEMALE; HUMAN; IN VITRO STUDY; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; MALE; MICROBUBBLE; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR VASCULARIZATION;

EID: 28044440499     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i36.5607     Document Type: Article

References (22)

1. Choi BI, Kim TK, Han JK, Kim AY, Seong CK, Park SJ. Vascularity of hepatoceller carcinoma: assessment with contrast-enhanced second-harmonic versus conventional power Doppler US. Radiology 2000; 214: 381-386
2. Hosten N, Puls R, Lemke AJ, Steger W, Zendel W, Zwicker C, Felix R. Contrastenhanced power Doppler sonography: Improved detection of characteristic flow patterns in focal liver lesions. J Clin Ultrasound 1999; 27: 107-115
3. Ding H, Kudo M, Onda H, Suetomi Y, Minami Y, Chung H, Kawasaki T, Maekawa K. Evaluation of Posttreatment Response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. Radiology 2001; 221: 721-730
4. Heckemann RA, Cosgrove DO, Blomley MJ, Eckersley RJ, Harvey CJ, Mine Y. Liver lesions: intermittent second-harmonic gray-scale US can increase conspicuity with microbubble contrast material - early experience. Radiology 2000; 216: 592-596
5. Harvey CJ, Blomley MJ, Eckersley RJ, Heckemann RA, Butler-Barnes J, Cosgrove DO. Pulse-inversion mode imaging of liver specific microbubbles:improved detection of subcentimetre metastases. The Lancet 2000; 355: 807-808
6. Blomley MJ, Albrecht T, Cosgrove DO, Patel N, Jayaram V, Butler-Barnes J, Eckersley RJ, Bauer A, Schlief R. Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: early experience. Radiology 1999; 210: 409-416
7. Burns PN, Wilson SR, Muradali D, Microbubble destruction is the origin of Harmonic signals from FS 069. Radiology 1996; 201: 158-159
8. Calliada F, Campani R, Bottinelli O, Bozzini A, Sommaruga MG. Ultrasound contrast agents basic principals. Eur J Radiol 1998; 27: 157-160
9. Wilson SR, Burns PN, Muradali D, Wilson JA, Lai X. Harmonic hepatic US with microbubble contrast agents:initial experience showing improved characterization of hemangioma, hepatocellular carcinoma,and metastasis. Radiology 2000; 215: 153-161
10. Blomley MJ, Albrecht T, Cosgrove DO, Eckersley RJ, Butler-Barnes J, Jayaram V, Patel N, Heckemann RA, Bauer A, Schlief R. Stimulated acoustic emission to image a late liver and spleen-specific phase of Levovist in normal volunteers and patients with and without liver disease. Ultrasound Med Biol 1999; 25: 1341-1352
11. Blomley MJ, Sidhu PS, Cosgrove DO, Albrecht T, Harvey CJ, Heckemann RA, Butler-Barnes J, Eckersley RJ, Basilico R. Do different types of liver lesions differ in their uptake of the microbubble contrast agent SH U 508A in the late liver phase? early experience. Radiology 2001; 220: 661-667
12. Kim TK, Choi BI, Han JK, Hong HS, Park SH, Moon SG. Hepatic tumors: contrast agent-enhancement patterns with pulse- inversion harmonic US. Radiology 2000; 216: 411-417
13. Harvey CJ, Blomley MJ, Eckersley RJ, Cosgrove DO, Patel N, Heckemann RA, Butler-Barnes J. Hepatic malignancies: improved detectio with pulse-inversion US in late phase of enhancement with SH U 508A-Early Experience. Radiology 2000; 216: 903-908
14. Yamamoto K, Shiraki K, Deguchi M, Sugimoto K, Sakai T, Ohmori S, Murata K, Hashimoto A, Shimizu A, Okuda Y, Nakano T. Diagnosis of hepatocellular carcinoma using digital subtraction imaging with the contrast agent, Levovist: Comparison with helical CT,Digital subtraction angiography, and US angiography. Oncol Reports 2002; 9: 789-792
15. Yamamoto K, Shiraki K, Nakanishi S, Deguchi M, Sugimoto K, Sakai T, Ohmori S, Murata K, Fuke H, Hashimoto A, Shimizu A, Okuda Y, Nakano T. The usefulness of digital subtraction imaging with Levovist in the diagnosis of focal hepatic tumors. Int J Oncol 2003; 22: 353-358
16. Kim AY, Choi BI, Kim TK, Han JK, Yun EJ, Lee KY, Han MC. Hepatocellular carcinoma:power Doppler US with a contrast agent-preliminary results. Radiology 1998; 209: 135-140
17. Kim TK, Han JK, Kim AY, Choi BI. Limitations of characterization of hepatic hemangiomas using a sonographic contrast agent (Levovist) and power Doppler ultrasonography. J Ultrasound Med 1999; 18: 737-743
18. Choi D, Lim HK, Kim SH, Lee WJ, Jang HJ, Lee JY, Paik SW, Koh KC, Lee JH. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results. Radiology 2000; 217: 558-563
19. Tetsuya K. Technical Description of 1.5-Harmonic Imaging, an Effective Technique for Contrast-Enhanced Ultrasound Diagnosis. Medical Review 2002; 87: 22-25
20. Tetsuya K, Yoshitaka M, Naohisa. New Imaging Method for High MI Contrast Imaging:1.5 Harmonic Imaging. J Ultrasound Med 2002; 29: 241
21. Kudo M, Tomita S, Tochio H, Kashida H, Hirasa M, Todo A. Hepatic focal nodular hyperplasia:specific findings at dynamic contrast-enhanced US with carbon dioxide microbubbles. Radiology 1991; 179: 377-382
22. 2 microbubbles. Radiology 1992; 182: 155-160